What is Chimera Investment Corporation's earnings per share (EPS)?

Chimera Investment Corporation (CIM) reported diluted earnings per share of $1.72 for fiscal year 2025. This represents a 56.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Chimera Investment Corporation (CIM) Financials

CIM NYSE

Trailing 12 months to June 30, 2026

Revenue Not reported for the trailing 12 months

Net Income $1.2M -99.4% YoY

EPS (Diluted) -$1.05 -182.7% YoY

Operating Cash Flow -$386.2M -419.8% YoY

Market Cap $702.3M as of Oct 26, 2026

Price / Sales n/m no revenue reported

Price / Earnings 580x on $1.2M net income, trailing 12 months to June 30, 2026

Price / Book 0.3x on $2.4B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 26, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 5, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 5, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CIM SEC filings page.

This page shows Chimera Investment Corporation (CIM) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CIM FY2025 2026-10-24

FY2025 shows an expanded asset base financed increasingly by liabilities, while reported earnings recovered without comparable equity growth.

Reported earnings moved from a net loss of $513M in FY2022 to net income of $230M in FY2025, a recovery that does not by itself describe stronger capital support. Meanwhile, liabilities grew 25.0% in FY2025 while equity grew only 1.8%, indicating that the latest expansion relied more on obligations than retained capital.

Reported assets expanded from $13.4B in FY2022 to $15.8B in FY2025, but the larger balance sheet did not translate into a larger shareholder capital base: total equity was $2.57B in FY2025 after $2.67B in FY2022.

FY2025 paired net income of $230M with operating cash flow of -$249M, so accounting earnings and cash movement pointed in opposite directions. For an investment company, portfolio activity can make cash flows move differently from reported earnings, making profit alone an incomplete view of the year's financial movement.

Financial Health Signals

Financial health score not available

Chimera Investment Corporation does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial

2/6

Chimera Investment Corporation passes 2 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).

Earnings Quality No Cash Backing

$1.08used

For every $1 of reported earnings, Chimera Investment Corporation used $1.08 of operating cash (-$248.9M OCF vs $230.5M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely.

Key Financial Metrics

Export CSV

Earnings & Revenue

Net Income

$17.4M

YoY-51.0%

QoQn/m

5Y CAGR-36.1%

10Y CAGR-13.5%

Chimera Investment Corporation reported $17.4M in net income in Q2 2026. This represents a decrease of 51.0% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

EPS (Diluted)

-$0.05

YoY-129.4%

QoQn/m

Chimera Investment Corporation earned -$0.05 per diluted share (EPS) in Q2 2026. This represents a decrease of 129.4% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Revenue

Not reported for Q2 2026.

EBITDA

Not reported for Q2 2026.

Cash & Balance Sheet

Cash & Debt

$444.0M

YoY+77.5%

QoQ-6.8%

5Y CAGR+5.1%

10Y CAGR+20.7%

Chimera Investment Corporation held $444.0M in cash against $252.6M in long-term debt as of Q2 2026.

Dividends Per Share

$0.45

YoY+21.6%

QoQ0.0%

Chimera Investment Corporation paid $0.45 per share in dividends in Q2 2026. This represents an increase of 21.6% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

84M

YoY+3.3%

QoQ+0.1%

Chimera Investment Corporation had 84M shares outstanding in Q2 2026. This represents an increase of 3.3% from the same quarter a year earlier. Against the prior quarter it is up 0.1%.

Free Cash Flow

Not reported for Q2 2026.

Margins & Returns

Return on Equity

0.7%

YoY-0.6pp

QoQ+2.5pp

5Y change-3.8pp

10Y change-1.8pp

Chimera Investment Corporation's quarterly ROE was 0.7% in Q2 2026: one quarter's net income over shareholder equity, not annualized. This is down 0.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.5 percentage points.

Gross Margin

Not reported for Q2 2026.

Operating Margin

Not reported for Q2 2026.

Net Margin

Not reported for Q2 2026.

Capital Allocation

None of these metrics is reported for Q2 2026.

CIM Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CIM quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
SG&A Expenses	$39.9M	$30.0M+29.3%	$23.2M-7.6%	$25.1M+10.9%	$22.7M+1.8%	$22.2M-2.9%	$22.9M-4.2%	$23.9M+5.5%	$22.7M+28.4%	$17.6M+0.8%	$17.5M-44.6%	$31.6M+55.0%	$20.4M+44.9%	$14.1M+0.7%	$14.0M+92.5%	$7.3M
Interest Expense	$593.6M	$554.9M+11.8%	$496.3M-2.6%	$509.5M+52.9%	$333.3M+2.0%	$326.6M-36.7%	$516.2M-32.0%	$758.8M+11.7%	$679.1M+27.5%	$532.7M+53.2%	$347.9M+34.1%	$259.4M+75.5%	$147.8M+44.9%	$102.0M-19.4%	$126.6M+959.9%	$11.9M
Income Tax	N/A	$2.3M+4528.6%	$49K-52.0%	$102Kn/m	-$253K-105.7%	$4.4M+2688.0%	$158K-18.1%	$193K+112.1%	$91K-15.7%	$108K+30.1%	$83K+8200.0%	$1K-50.0%	$2K0.0%	$2K+100.0%	$1K-99.8%	$606K
Net Income	$1.2M	$230.5M+30.9%	$176.1M+39.6%	$126.1Mn/m	-$513.1M-176.6%	$670.1M+654.2%	$88.9M-78.5%	$413.6M+0.5%	$411.6M-21.5%	$524.7M-4.9%	$551.9M+120.5%	$250.3M-57.5%	$589.2M+62.5%	$362.7M+10.7%	$327.8M+138.7%	$137.3M
EPS (Basic)	N/A	$1.76+57.1%	$1.12	$0.68	-$7.53	$2.55	$0.07	$1.82-7.6%	$1.97-24.8%	$2.62-10.6%	$2.93+134.4%	$1.25	$2.87+62.1%	$1.77	$0.32+146.2%	$0.13
EPS (Diluted)	-$1.05	$1.72+56.4%	$1.10	$0.68	-$7.53	$2.44	$0.07	$1.81-7.7%	$1.96-24.9%	$2.61-10.6%	$2.92+133.6%	$1.25	$2.87+63.1%	$1.76	$0.32+146.2%	$0.13
Diluted Shares (Avg)	N/A	84M+2.2%	82M	78M	78M	245M	226M	188M+0.4%	188M-0.3%	188M+0.1%	188M-5.8%	200M	206M0.0%	206M	1.03B0.0%	1.03B

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-K
SG&A Expenses	$11.5M+68.4%	$12.2M+76.1%	$9.3M+66.8%	$6.9M+23.6%	$6.8M+8.6%	$6.9M+20.8%	$5.6M-24.8%	$5.6M+3.4%
Interest Expense	$151.1M+11.7%	$144.3M+18.9%	$154.2M+21.8%	$144.1M+11.8%	$135.3M+13.3%	$121.4M-0.1%	$126.5M0.0%	$128.8M-2.5%
Income Tax	-$301K-173.6%	-$2.1M-217.6%	N/A	$251K+1468.8%	$409K+1219.4%	$1.8M+21837.5%	N/A	$16K-78.7%
Net Income	$17.4M-51.0%	-$43.9M-126.2%	$28.3Mn/m	-$580K-100.4%	$35.5M-37.4%	$167.3M+29.2%	-$146.5M-579.7%	$136.5M+6188.4%
EPS (Basic)	-$0.05-129.4%	-$0.78	$0.08	-$0.27	$0.17	$1.79	-$2.07	$1.41
EPS (Diluted)	-$0.05-129.4%	-$0.78	$0.05	-$0.27	$0.17	$1.77	-$2.06	$1.39
Diluted Shares (Avg)	84M+1.5%	84M	N/A	82M	83M	82M	N/A	82M

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, Operating Income, EBITDA.

CIM Balance Sheet

CIM quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$15.8B+20.5%	$13.1B+1.5%	$12.9B-3.5%	$13.4B-13.0%	$15.4B-12.1%	$17.5B-35.4%	$27.1B-2.1%	$27.7B+30.6%	$21.2B+27.2%	$16.7B+8.7%	$15.3B-19.9%	$19.2B+176.2%	$6.9B-10.4%	$7.7B-0.1%	$7.7B
Cash & Equivalents	$278.6M+231.7%	$84.0M-62.1%	$221.7M-16.2%	$264.6M-31.4%	$385.7M+43.4%	$269.1M+144.9%	$109.9M+131.4%	$47.5M-25.3%	$63.6M-64.2%	$177.7M+55.8%	$114.1M-30.7%	$164.6M+112.1%	$77.6M-87.5%	$621.2M+201.1%	$206.3M
Total Liabilities	$13.2B+25.0%	$10.6B+2.1%	$10.4B-3.4%	$10.7B-8.0%	$11.7B-15.1%	$13.7B-40.7%	$23.2B-3.5%	$24.0B+36.5%	$17.6B+29.7%	$13.6B+9.4%	$12.4B-20.3%	$15.5B+331.3%	$3.6B-14.2%	$4.2B-10.6%	$4.7B
Long-Term Debt	$251.5M+86.8%	$134.6Mn/m	$0	N/A	$0-100.0%	$51.6Mn/m	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$2.6B+1.8%	$2.5B-1.3%	$2.6B-4.0%	$2.7B-28.6%	$3.7B-1.1%	$3.8B-4.4%	$4.0B+6.7%	$3.7B+1.9%	$3.6B+16.4%	$3.1B+6.0%	$2.9B-18.3%	$3.6B+8.3%	$3.3B-6.0%	$3.5B+16.2%	$3.0B
Retained Earnings	$4.6B+5.3%	$4.3B+4.2%	$4.2B+3.1%	$4.0B-11.3%	$4.6B+17.3%	$3.9B+2.3%	$3.8B+12.2%	$3.4B+13.9%	$3.0B+21.5%	$2.4B+29.2%	$1.9Bn/m	-$1.1Bn/m	-$1.3Bn/m	-$1.1Bn/m	-$999.8M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-K
Total Assets	$16.0B+8.0%	$16.0B+21.0%	$15.8B+20.5%	$15.1B+10.3%	$14.9B+13.2%	$13.2B+5.3%	$13.1B+1.5%	$13.7B+6.3%
Cash & Equivalents	$444.0M+77.5%	$476.2M+88.0%	$278.6M+231.7%	$491.5M+405.0%	$250.2M+54.2%	$253.3M+49.9%	$84.0M-62.1%	$97.3M-29.8%
Total Liabilities	$13.6B+11.4%	$13.5B+28.0%	$13.2B+25.0%	$12.5B+14.4%	$12.2B+16.7%	$10.6B+6.7%	$10.6B+2.1%	$11.0B+5.5%
Long-Term Debt	$252.6M+86.8%	$252.0M+86.8%	$251.5M+86.8%	$251.0M+86.7%	$135.2M+116.6%	$134.9M	$134.6Mn/m	$134.4M
Total Equity	$2.4B-8.0%	$2.5B-6.8%	$2.6B+1.8%	$2.6B-6.1%	$2.6B-0.6%	$2.6B-0.1%	$2.5B-1.3%	$2.7B+9.7%
Retained Earnings	$4.5B0.0%	$4.5B+0.4%	$4.6B+5.3%	$4.5B+1.2%	$4.5B+4.4%	$4.5B+5.0%	$4.3B+4.2%	$4.5B+8.5%

Not reported in any period shown, so not listed: Current Assets, Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments, Goodwill, Current Liabilities, Non-Current Liabilities.

CIM Cash Flow Statement

CIM quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	-$386.2M	-$248.9M-221.0%	$205.7M-3.6%	$213.3M-34.5%	$325.7M-37.3%	$519.2M+101.3%	$257.9M+296.6%	$65.0M-78.1%	$297.6M-38.9%	$487.3M-11.9%	$552.9M+39.5%	$396.3M+116.8%	$182.8M-40.0%	$304.8M-9.0%	$334.9M-25.2%	$447.7M
Stock-Based Compensation	N/A	$9.7M-4.0%	$10.1M+5.7%	$9.6M+16.8%	$8.2M+25.5%	$6.5M+29.8%	$5.0M-52.6%	$10.6M+20.3%	$8.8M+119.9%	$4.0M+100.0%	$2.0M+100.0%	$1.0M+502.4%	$166K	N/A	N/A	N/A
Investing Cash Flow	-$280.5M	-$1.7B-1029.8%	$178.2M-67.7%	$551.8M+8.2%	$509.8M-80.0%	$2.5B-69.4%	$8.3B+573.5%	$1.2Bn/m	-$6.0Bn/m	-$4.3Bn/m	-$1.3B-162.3%	$2.0B	N/A	N/A	N/A	N/A
Financing Cash Flow	$867.8M	$2.1Bn/m	-$521.6Mn/m	-$807.9Mn/m	-$956.7Mn/m	-$3.0Bn/m	-$8.4Bn/m	-$1.2B-121.7%	$5.7B+53.2%	$3.7B+377.4%	$781.3Mn/m	-$2.5B	N/A	N/A	N/A	N/A
Dividends Paid	$131.9M	$122.7M+3.0%	$119.1M-39.0%	$195.2M-32.2%	$287.7M-3.6%	$298.6M-7.4%	$322.6M-13.8%	$374.3M0.0%	$374.4M-0.4%	$375.8M-17.3%	$454.3M+19.2%	$381.2M-33.7%	$575.3M+55.6%	$369.7M-10.0%	$410.7M-29.8%	$585.0M
Share Buybacks	N/A	$0n/m	$0-100.0%	$33.1M-32.3%	$48.9M+2574.3%	$1.8M-91.7%	$22.1Mn/m	$0-100.0%	$14.8Mn/m	$0n/m	$0-100.0%	$250.0Mn/m	$0	N/A	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-K
Operating Cash Flow	-$339.2Mn/m	$243.3M+398.6%	-$152.8M-502.6%	-$137.5M-431.9%	-$7.4M-110.8%	$48.8M-14.8%	$38.0M+21.1%	$41.4M-7.3%
Depreciation & Amortization	N/A	N/A	$4.3M+1249.5%	$948Kn/m	$949Kn/m	$951Kn/m	$321K	$0
Stock-Based Compensation	$3.0M+50.0%	$2.7M-27.2%	N/A	$2.0M0.0%	$2.0M0.0%	$3.7M+25.5%	N/A	$2.0M0.0%
Investing Cash Flow	-$357.4Mn/m	$355.7Mn/m	-$337.0M-148.9%	$58.1Mn/m	-$1.2Bn/m	-$175.3M-170.6%	$689.7M+83.0%	-$646.2M-275.7%
Financing Cash Flow	$664.9M-44.9%	-$400.5M-235.4%	$282.8Mn/m	$320.6M-40.6%	$1.2B+3088.6%	$295.9Mn/m	-$740.9Mn/m	$539.8Mn/m
Dividends Paid	$37.7M+24.7%	$32.4M+5.8%	$31.9M+5.9%	$30.0M-14.1%	$30.2M+11.0%	$30.6M+14.1%	$30.1M-29.5%	$34.9M-20.6%
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	$0n/m	$0-100.0%

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow.

CIM Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CIM quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Return on Equity	9.0%+2.0pp	7.0%+2.0pp	4.9%+24.2pp	-19.2%-37.2pp	17.9%+15.6pp	2.4%-8.1pp	10.5%-0.7pp	11.1%-3.3pp	14.4%-3.2pp	17.7%+9.2pp	8.5%-7.8pp	16.3%+5.4pp	10.9%+1.6pp	9.3%+4.7pp	4.5%
Return on Assets	1.5%+0.1pp	1.3%+0.4pp	1.0%+4.8pp	-3.8%-8.2pp	4.3%+3.8pp	0.5%-1.0pp	1.5%0.0pp	1.5%-1.0pp	2.5%-0.8pp	3.3%+1.7pp	1.6%-1.5pp	3.1%-2.1pp	5.2%+1.0pp	4.2%+2.5pp	1.8%
Debt-to-Equity	0.100.0x	0.05+0.1x	0.00	N/A	0.000.0x	0.010.0x	0.00	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Liabilities-to-Equity	5.14+1.0x	4.19+0.1x	4.050.0x	4.03+0.9x	3.12-0.5x	3.64-2.2x	5.86-0.6x	6.48+1.6x	4.84+0.5x	4.34+0.1x	4.21-0.1x	4.31+3.2x	1.08-0.1x	1.19-0.4x	1.54

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-K
Return on Equity	0.7%-0.6pp	-1.8%-8.1pp	1.1%+6.9pp	0.0%-5.0pp	1.4%-0.8pp	6.3%+1.4pp	-5.8%-7.0pp	5.0%+4.9pp
Return on Assets	0.1%-0.1pp	-0.3%-1.5pp	0.2%+1.3pp	0.0%-1.0pp	0.2%-0.2pp	1.3%+0.2pp	-1.1%-1.4pp	1.0%+1.0pp
Debt-to-Equity	0.10+0.1x	0.10+0.1x	0.100.0x	0.100.0x	0.050.0x	0.05	0.05+0.1x	0.05
Liabilities-to-Equity	5.64+1.0x	5.49+1.5x	5.14+1.0x	4.88+0.9x	4.66+0.7x	3.99+0.3x	4.19+0.1x	4.01-0.2x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Current Ratio, Asset Turnover, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Chimera Investment Corporation CIM	FY2025	N/A	$230.5M	N/A	$702.3M	—
Orchid Island Capital, Inc. ORC	FY2025	$414.0M	$159.0M	38.4%	$972.7M	—
PennyMac Mortgage Investment Trust PMT	FY2025	$307.5M	$127.9M	41.6%	$615.6M	—
MFA Financial, Inc. MFA	FY2025	$745.1M	$176.8M	23.7%	$671.2M	—
Apollo Commercial Real Estate Finance, Inc. ARI	FY2025	$271.6M	$126.7M	46.7%	$848.4M	49/100

Where Chimera Investment Corporation Ranks

Frequently Asked Questions

Is Chimera Investment Corporation profitable?

Yes, Chimera Investment Corporation (CIM) reported a net income of $1.2M over the trailing 12 months to June 30, 2026. In fiscal year 2025 it reported a net income of $230.5M.

How much debt does Chimera Investment Corporation have?

As of fiscal year 2025, Chimera Investment Corporation (CIM) had $278.6M in cash and equivalents against $251.5M in long-term debt.

Does Chimera Investment Corporation pay dividends?

Yes, Chimera Investment Corporation (CIM) paid $1.48 per share in dividends during fiscal year 2025.

What is Chimera Investment Corporation's return on equity (ROE)?

Chimera Investment Corporation (CIM) has a return on equity of 9.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Chimera Investment Corporation's operating cash flow?

Chimera Investment Corporation (CIM) recorded an outflow of $248.9M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are Chimera Investment Corporation's total assets?

Chimera Investment Corporation (CIM) had $15.8B in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does Chimera Investment Corporation have outstanding?

Chimera Investment Corporation (CIM) had 83M shares outstanding as of fiscal year 2025.

What is Chimera Investment Corporation's debt-to-equity ratio?

Chimera Investment Corporation (CIM) had a debt-to-equity ratio of 0.10 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

What is Chimera Investment Corporation's liabilities-to-equity ratio?

Chimera Investment Corporation (CIM) had a liabilities-to-equity ratio of 5.14 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

What is Chimera Investment Corporation's return on assets (ROA)?

Chimera Investment Corporation (CIM) had a return on assets of 1.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Chimera Investment Corporation's P/E ratio?

Chimera Investment Corporation (CIM) trades at 580x earnings, its market capitalization divided by $1.2M net income, trailing 12 months to June 30, 2026. The market capitalization is $702.3M as of Oct 26, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Chimera Investment Corporation's price-to-sales ratio?

Chimera Investment Corporation (CIM) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $702.3M as of Oct 26, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Chimera Investment Corporation's Piotroski F-Score?

Chimera Investment Corporation (CIM) has a Piotroski F-Score of 2 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Chimera Investment Corporation's earnings high quality?

For every $1 of reported earnings, Chimera Investment Corporation (CIM) used $1.08 of operating cash (-$248.9M OCF vs $230.5M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.